Neuropharm
UK Biotech: time for bold and affirmative action
January 22, 2009Research and Development, Sales and Marketing BTG, Chris Collins, Christopher Evans, Neuropharm, Plethora, UK, biotech, pharma, strategy
Biotech leaders in the UK say the cash-stricken industry has reached ‘breaking point’, and have made an unprecedented plea for …
Latest content
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
